Bank Of America Corp Cue Biopharma, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 239,202 shares of CUE stock, worth $251,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

239,202

Previous 242,568 1.39%

Holding current value

$251,162

Previous $300,000 39.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.45 - $1.08 $1,514 - $3,635	-3,366 Reduced 1.39%	239,202 $181,000
Q2 2024 Aug 14, 2024	SELL	$1.24 - $2.18 $1,299 - $2,284	-1,048 Reduced 0.43%	242,568 $300,000
Q1 2024 May 15, 2024	SELL	$1.77 - $3.09 $40,021 - $69,867	-22,611 Reduced 8.49%	243,616 $460,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.1 $194,446 - $350,455	113,050 Added 73.8%	266,227 $702,000
Q2 2023 Aug 14, 2023	SELL	$3.11 - $4.91 $44,528 - $70,301	-14,318 Reduced 8.55%	153,177 $559,000
Q1 2023 May 12, 2023	BUY	$2.41 - $3.74 $169,811 - $263,524	70,461 Added 72.61%	167,495 $597,000
Q4 2022 Feb 10, 2023	SELL	$2.39 - $3.95 $39,382 - $65,088	-16,478 Reduced 14.52%	97,034 $276,000
Q3 2022 Nov 14, 2022	BUY	$2.23 - $3.37 $194,458 - $293,867	87,201 Added 331.42%	113,512 $253,000
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $163,319 - $388,292	-65,590 Reduced 71.37%	26,311 $0
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $102,175 - $284,515	-23,169 Reduced 20.13%	91,901 $449,000
Q4 2021 Feb 08, 2022	BUY	$10.86 - $17.85 $903,475 - $1.48 Million	83,193 Added 260.98%	115,070 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$10.06 - $15.3 $18,470 - $28,090	1,836 Added 6.11%	31,877 $464,000
Q2 2021 Sep 13, 2021	BUY	$10.9 - $14.53 $327,446 - $436,495	30,041 New	30,041 $350,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $37.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cue Biopharma, Inc. Transaction History